Attachment B Salient Characteristics - Immunoassy Testing Reagents.docx
DOCX document 18 KB Posted
- Attached to
- 6550--IMMUNOASSAY REAGENTS VISN 22 Federal contract opportunity
- Solicitation number
- 36C26224Q0423
About this file
This document outlines salient characteristics for immunoassay testing reagents and related consumables required by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The reagents and supplies must be compatible with existing DiaSorin Liaison XL instruments using Flash CLIA technology with a paramagnetic microparticle solid phase. All assays must have a minimum of FDA Emergency Use Authorization approval for SARS-CoV-2 testing and be based on a two-part internal master curve calibration. Reagents and consumables must be ready to use without preparation and include barcodes for instrument identification. Delivery must be within three business days of order receipt and include shipping to FOB destination locations. Service is also required for one DiaSorin Liaison XL instrument at the Long Beach location.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| 36C26224Q0423.docx | DOCX document | |
| Attachment A.xlsx | XLSX spreadsheet | |
| P02 RFI IMMUNOCHEMISTRY REAGENTS.docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Salient Characteristics Reagents, supplies and consumables must:
1. All reagents, supplies, and consumables must be compatible with existing DiaSorin Liaison XL instruments for immunoassay testing through “Flash” chemiluminescence technology (CLIA) with a paramagnetic microparticle solid phase (MP).
2. The use of the reagents, supplies, and consumables must not void the warranty on existing DiaSorin Liaison XL instruments.
3. The vendor shall provide the facilities with Food and Drug Administration (FDA) approved reagents and any consumable parts necessary for analyzing/testing on all instruments.
4. The vendor shall provide the facilities with at minimum Emergency Use Authorization (EUA) Food and Drug Administration (FDA) approved SARS-CoV-2 reagents and any consumable parts necessary for analyzing/testing on all instruments.
5. All assays must at minimum be based internal master curve with a two-part calibration.
6. All reagents and consumables shall be ready to use (i.e. no preparation by staff to prior to use).
7. All reagents and consumables shall have barcodes for instrument identification.
8. Service for one DiaSorin Liaison XL instruments at Long beach location.
Other Requirements
1. All shipping shall be inclusive of prices within the schedule and FOB Destination.
2. Orders must be delivered within three business days After Receipt of Order.
File details come from the government source that posted it. Updated .